Literature DB >> 17301176

Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity.

Elena Marcello1, Fabrizio Gardoni, Daniela Mauceri, Stefano Romorini, Andreas Jeromin, Roberta Epis, Barbara Borroni, Flaminio Cattabeni, Carlo Sala, Alessandro Padovani, Monica Di Luca.   

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative disorder caused by a combination of events impairing normal neuronal function. Here we found a molecular bridge between key elements of primary and secondary pathogenic events in AD, namely the elements of the amyloid cascade and synaptic dysfunction associated with the glutamatergic system. In fact, we report that synapse-associated protein-97 (SAP97), a protein involved in dynamic trafficking of proteins to the excitatory synapse, is responsible for driving ADAM10 (a disintegrin and metalloproteinase 10, the most accredited candidate for alpha-secretase) to the postsynaptic membrane, by a direct interaction through its Src homology 3 domain. NMDA receptor activation mediates this event and positively modulates alpha-secretase activity. Furthermore, perturbing ADAM10/SAP97 association in vivo by cell-permeable peptides impairs ADAM10 localization in postsynaptic membranes and consequently decreases the physiological amyloid precursor protein (APP) metabolism. Our findings indicate that glutamatergic synapse activation through NMDA receptor promotes the non-amyloidogenic APP cleavage, strengthening the correlation between APP metabolism and synaptic plasticity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301176      PMCID: PMC6673742          DOI: 10.1523/JNEUROSCI.3439-06.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

Review 1.  Physiological functions of the amyloid precursor protein secretases ADAM10, BACE1, and presenilin.

Authors:  Johannes Prox; Andrea Rittger; Paul Saftig
Journal:  Exp Brain Res       Date:  2011-11-27       Impact factor: 1.972

Review 2.  Regulation of α-secretase ADAM10 expression and activity.

Authors:  Kristina Endres; Falk Fahrenholz
Journal:  Exp Brain Res       Date:  2011-10-04       Impact factor: 1.972

Review 3.  New developments on the role of NMDA receptors in Alzheimer's disease.

Authors:  Roberto Malinow
Journal:  Curr Opin Neurobiol       Date:  2011-09-29       Impact factor: 6.627

Review 4.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

Review 5.  The amyloid cascade: the old and the new.

Authors:  E Marcello; R Epis; F Gardoni; M Di Luca
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

Review 6.  Abeta, oxidative stress in Alzheimer disease: evidence based on proteomics studies.

Authors:  Aaron M Swomley; Sarah Förster; Jierel T Keeney; Judy Triplett; Zhaoshu Zhang; Rukhsana Sultana; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2013-10-09

7.  FE65 proteins regulate NMDA receptor activation-induced amyloid precursor protein processing.

Authors:  Jaehong Suh; Alvin Lyckman; Lirong Wang; Elizabeth A Eckman; Suzanne Y Guénette
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

8.  Apparent reduction of ADAM10 in scrapie-infected cultured cells and in the brains of scrapie-infected rodents.

Authors:  Cao Chen; Yan Lv; Bao-Yun Zhang; Jin Zhang; Qi Shi; Jing Wang; Chan Tian; Chen Gao; Kang Xiao; Ke Ren; Wei Zhou; Xiao-Ping Dong
Journal:  Mol Neurobiol       Date:  2014-04-26       Impact factor: 5.590

Review 9.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

10.  Neuronal activity and secreted amyloid β lead to altered amyloid β precursor protein and presenilin 1 interactions.

Authors:  Xuejing Li; Kengo Uemura; Tadafumi Hashimoto; Navine Nasser-Ghodsi; Muriel Arimon; Christina M Lill; Isabella Palazzolo; Dimitri Krainc; Bradley T Hyman; Oksana Berezovska
Journal:  Neurobiol Dis       Date:  2012-10-12       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.